Related Experiment Videos
High-dose oxytocin: 20- versus 40-minute dosage interval
A J Satin1, K J Leveno, M L Sherman
1Department of Obstetrics and Gynecology, Wilford Hall United States Air Force Medical Center, Lackland AFB, Texas.
Obstetrics and Gynecology
|February 1, 1994
Summary
Increasing the oxytocin dosing interval to 40 minutes did not clearly benefit labor induction or augmentation. Both 20- and 40-minute intervals for oxytocin are safe and effective, with no impact on neonatal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pharmacology in Pregnancy
Background:
- High-dose oxytocin is frequently used for labor induction and augmentation.
- The optimal dosing interval for high-dose oxytocin to balance efficacy and safety is not well-established.
- Uterine hyperstimulation and cesarean delivery are potential adverse outcomes associated with oxytocin use.
Purpose of the Study:
- To investigate if increasing the oxytocin dosing interval from 20 to 40 minutes reduces the incidence of uterine hyperstimulation.
- To compare the rates of cesarean delivery for dystocia and fetal distress between 20- and 40-minute oxytocin dosing intervals.
- To evaluate the impact of different oxytocin dosing intervals on neonatal outcomes.
Main Methods:
- A comparative study of 1801 pregnancies receiving high-dose oxytocin for labor induction or augmentation.
- Comparison of 20-minute versus 40-minute oxytocin dosing intervals.
- Statistical analysis using chi-squared, Fisher's exact, and Wilcoxon rank-sum tests, with multivariate logistic regression and analysis of covariance to control for confounding variables.
Main Results:
- No significant difference in cesarean delivery rates for dystocia or fetal distress between 20- and 40-minute intervals during labor induction.
- The 20-minute interval for augmentation was associated with a significant reduction in cesarean delivery for dystocia (P = .05).
- The 40-minute interval for induction showed a lower incidence of uterine hyperstimulation (31% vs. 40%, P = .02), but this was not observed during augmentation (28% vs. 31%).
- Neonatal outcomes were not affected by the dosing interval in either induction or augmentation groups.
Conclusions:
- A 40-minute oxytocin dosing interval offers no clear advantage over a 20-minute interval for high-dose oxytocin use.
- Both 20- and 40-minute intervals are safe and efficient, with comparable perinatal outcomes.
- The 20-minute interval may reduce cesarean rates for dystocia during augmentation, while the 40-minute interval may decrease hyperstimulation during induction.